Patent blue-enhanced lymphaticovenular anastomosis.
Identifieur interne : 001E18 ( PubMed/Corpus ); précédent : 001E17; suivant : 001E19Patent blue-enhanced lymphaticovenular anastomosis.
Auteurs : Benoit Ayestaray ; Farid Bekara ; Jean-Baptiste AndreolettiSource :
- Journal of plastic, reconstructive & aesthetic surgery : JPRAS [ 1878-0539 ] ; 2013.
English descriptors
- KwdEn :
- Aged, Anastomosis, Surgical (methods), Chronic Disease, Cohort Studies, Female, Follow-Up Studies, Humans, Image Enhancement (methods), Lymphatic Vessels (surgery), Lymphedema (physiopathology), Lymphedema (surgery), Male, Microsurgery (methods), Middle Aged, Retrospective Studies, Rosaniline Dyes, Treatment Outcome, Upper Extremity (surgery).
- MESH :
- chemical : Rosaniline Dyes.
- methods : Anastomosis, Surgical, Image Enhancement, Microsurgery.
- physiopathology : Lymphedema.
- surgery : Lymphatic Vessels, Lymphedema, Upper Extremity.
- Aged, Chronic Disease, Cohort Studies, Female, Follow-Up Studies, Humans, Male, Middle Aged, Retrospective Studies, Treatment Outcome.
Abstract
Lymphoedema supermicrosurgery is known to be difficult to perform. Lymphatic vessels are not easy to individualise, because of their small calibre (inferior to 1 mm) and their translucent appearance. Patent blue is an organic colourant, which is able to enhance the lymphatic network. We have evaluated the morbidity and the efficacy of patent blue lymphatic enhancement, with a view to perform lymphaticovenular anastomosis.
DOI: 10.1016/j.bjps.2012.10.019
PubMed: 23218656
Links to Exploration step
pubmed:23218656Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Patent blue-enhanced lymphaticovenular anastomosis.</title><author><name sortKey="Ayestaray, Benoit" sort="Ayestaray, Benoit" uniqKey="Ayestaray B" first="Benoit" last="Ayestaray">Benoit Ayestaray</name><affiliation><nlm:affiliation>Department of Plastic and Reconstructive Surgery, Nimes University Hospital, pl Pr Robert Debré, 30000 Nimes, France. bayestaray@yahoo.fr</nlm:affiliation></affiliation></author><author><name sortKey="Bekara, Farid" sort="Bekara, Farid" uniqKey="Bekara F" first="Farid" last="Bekara">Farid Bekara</name></author><author><name sortKey="Andreoletti, Jean Baptiste" sort="Andreoletti, Jean Baptiste" uniqKey="Andreoletti J" first="Jean-Baptiste" last="Andreoletti">Jean-Baptiste Andreoletti</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23218656</idno><idno type="pmid">23218656</idno><idno type="doi">10.1016/j.bjps.2012.10.019</idno><idno type="wicri:Area/PubMed/Corpus">001E18</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001E18</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Patent blue-enhanced lymphaticovenular anastomosis.</title><author><name sortKey="Ayestaray, Benoit" sort="Ayestaray, Benoit" uniqKey="Ayestaray B" first="Benoit" last="Ayestaray">Benoit Ayestaray</name><affiliation><nlm:affiliation>Department of Plastic and Reconstructive Surgery, Nimes University Hospital, pl Pr Robert Debré, 30000 Nimes, France. bayestaray@yahoo.fr</nlm:affiliation></affiliation></author><author><name sortKey="Bekara, Farid" sort="Bekara, Farid" uniqKey="Bekara F" first="Farid" last="Bekara">Farid Bekara</name></author><author><name sortKey="Andreoletti, Jean Baptiste" sort="Andreoletti, Jean Baptiste" uniqKey="Andreoletti J" first="Jean-Baptiste" last="Andreoletti">Jean-Baptiste Andreoletti</name></author></analytic><series><title level="j">Journal of plastic, reconstructive & aesthetic surgery : JPRAS</title><idno type="eISSN">1878-0539</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Anastomosis, Surgical (methods)</term><term>Chronic Disease</term><term>Cohort Studies</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Image Enhancement (methods)</term><term>Lymphatic Vessels (surgery)</term><term>Lymphedema (physiopathology)</term><term>Lymphedema (surgery)</term><term>Male</term><term>Microsurgery (methods)</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Rosaniline Dyes</term><term>Treatment Outcome</term><term>Upper Extremity (surgery)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Rosaniline Dyes</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Anastomosis, Surgical</term><term>Image Enhancement</term><term>Microsurgery</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Lymphatic Vessels</term><term>Lymphedema</term><term>Upper Extremity</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Chronic Disease</term><term>Cohort Studies</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Retrospective Studies</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphoedema supermicrosurgery is known to be difficult to perform. Lymphatic vessels are not easy to individualise, because of their small calibre (inferior to 1 mm) and their translucent appearance. Patent blue is an organic colourant, which is able to enhance the lymphatic network. We have evaluated the morbidity and the efficacy of patent blue lymphatic enhancement, with a view to perform lymphaticovenular anastomosis.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23218656</PMID><DateCreated><Year>2013</Year><Month>02</Month><Day>12</Day></DateCreated><DateCompleted><Year>2013</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2016</Year><Month>11</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-0539</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>3</Issue><PubDate><Year>2013</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of plastic, reconstructive & aesthetic surgery : JPRAS</Title><ISOAbbreviation>J Plast Reconstr Aesthet Surg</ISOAbbreviation></Journal><ArticleTitle>Patent blue-enhanced lymphaticovenular anastomosis.</ArticleTitle><Pagination><MedlinePgn>382-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bjps.2012.10.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1748-6815(12)00620-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lymphoedema supermicrosurgery is known to be difficult to perform. Lymphatic vessels are not easy to individualise, because of their small calibre (inferior to 1 mm) and their translucent appearance. Patent blue is an organic colourant, which is able to enhance the lymphatic network. We have evaluated the morbidity and the efficacy of patent blue lymphatic enhancement, with a view to perform lymphaticovenular anastomosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">From November 2010 to January 2012, 20 patients with chronic lymphoedema of the upper limb were treated by lymphaticovenular anastomosis. The mean age of the patients was 60.1 years (range, 47-78 years). The mean duration of lymphoedema was 3.2 years (range, 1-9 years). The mean volume of patent blue injected subdermally before surgery was 1.3 ml (range, 1-2 ml). The number and the calibre of enhanced lymphatic vessels at each operative site were noted. The quality of patent blue enhancement was analysed. The efficacy of surgery was assessed by quantitative measures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean number of coloured lymphatic vessels per operative site was 2.1 (range, 1-4). The calibre of lymphatic vessels ranged from 0.3 to 0.8 mm (average, 0.57 mm). The quality of enhancement was moderate in two patients (8%), good in nine patients (36%) and excellent in 14 patients (56%). The mean number of lymphaticovenular anastomosis performed per operative site was 2.8 (range, 2-4). The mean operative time was 2.3 h (range, 2-3 h). No allergic (0%) and infectious (0%) reactions secondary to patent blue injection occurred. No secondary lymphangitis (0%) was noted. The delay of skin resorption of the blue stain ranges from 20 to 45 days (average, 30.3 days). Four patients (20%) had a remaining blue staining at the injection site. The average circumferential differential reduction rate was 13.2% (range, 4.2-27.2%) (p<0.001). The average cross-sectional area differential reduction rate was 24.1% (range, 9.5-46.7%) (p<0.001). The average volume differential reduction rate was 22.8% (range, 7.2-48.8%) (p<0.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Patent blue-enhanced lymphaticovenular anastomosis is a safe and effective technique to treat patients with secondary lymphoedema. Its ease of use, low cost and efficiency should make it used on a priority basis to perform lymphaticovenular anastomosis.</AbstractText><CopyrightInformation>Crown Copyright © 2012. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ayestaray</LastName><ForeName>Benoit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Plastic and Reconstructive Surgery, Nimes University Hospital, pl Pr Robert Debré, 30000 Nimes, France. bayestaray@yahoo.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bekara</LastName><ForeName>Farid</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Andreoletti</LastName><ForeName>Jean-Baptiste</ForeName><Initials>JB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Plast Reconstr Aesthet Surg</MedlineTA><NlmUniqueID>101264239</NlmUniqueID><ISSNLinking>1748-6815</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012394">Rosaniline Dyes</NameOfSubstance></Chemical><Chemical><RegistryNumber>FH1929ICIT</RegistryNumber><NameOfSubstance UI="C008769">sulfan blue</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007089" MajorTopicYN="N">Image Enhancement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042601" MajorTopicYN="N">Lymphatic Vessels</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008866" MajorTopicYN="N">Microsurgery</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012394" MajorTopicYN="Y">Rosaniline Dyes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034941" MajorTopicYN="N">Upper Extremity</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>07</Month><Day>02</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>09</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>12</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>12</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23218656</ArticleId><ArticleId IdType="pii">S1748-6815(12)00620-1</ArticleId><ArticleId IdType="doi">10.1016/j.bjps.2012.10.019</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E18 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001E18 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:23218656
|texte= Patent blue-enhanced lymphaticovenular anastomosis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23218656" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |